辛伐他汀对急性脑梗死患者血清CRP及IL―6水平的影响探讨.docVIP

辛伐他汀对急性脑梗死患者血清CRP及IL―6水平的影响探讨.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
辛伐他汀对急性脑梗死患者血清CRP及IL―6水平的影响探讨.doc

辛伐他汀对急性脑梗死患者血清CRP及IL―6水平的影响探讨   【摘要】 目的:研究分析急性脑梗死患者采用辛伐他汀治疗后血清白细胞介素-6(IL-6)以及血清C-反应蛋白(CRP)的水平变化情况。方法:选取2013年3月-2014年9月在本院就诊的60例急性脑梗死(ACI)患者随机分为治疗组和对照组,每组各30例患者。治疗组在常规综合对症治疗基础上配合辛伐他汀治疗,对照组单独采用常规综合对症处理,分别采用速率散射比浊法、放射免疫分析法测定两组患者治疗前后CRP及IL-6水平变化。结果:治疗组治疗总有效率为90%,对照组治疗总有效率为70%,治疗组治疗总有效率较对照组明显偏高,两组比较差异有统计学意义(P0.05),经相应治疗后两组患者IL-6、CRP水平较治疗前均有所下降,差异有统计学意义(P0.05),但是治疗组患者治疗后IL-6、CRP水平均低于对照组,差异有统计学意义(P0.05)。结论:急性脑梗死患者采用辛伐他汀治疗的临床效果显著,可有效降低患者血清IL-6及CRP水平,抗炎效果较好。   【关键词】 急性脑梗死; 辛伐他汀; 血清IL-6; 血清CRP; 影响分析   【Abstract】 Objective:To analyze the patients with acute cerebral infarction after simvastatin treatment using serum interleukin-6(IL-6), and serum C-reactive protein (CRP) level changes in circumstances。Method:60 patients of acute cerebral infarction (ACI) in our hospital were selected from March 2013 to September 2014,and randomly divided into treatment group and control group,30 cases in each group.The treatment group was treated in the routine based on symptomatic treatment with simvastatin,the control group was treated by conventional integrated symptomatic treatment alone.Before and after treatment,the rate nephelometry and radioimmunoassay were respectively used to measured the groups’ CRP and IL-6 levels.Result:The total effective rate of treatment group was 90%,the total effective rate of control group was 70%, the total efficiency of the treatment group compared with the control group was significantly higher,the difference was statistically significant(P0.05);after treatment, the patients via the corresponding IL-6 and CRP levels were decreased compared with before treatment,the difference was statistically significant (P0.05),but the treatment group’s patients with IL-6 and CRP levels were lower than the control group, the difference was statistically significant comparison(P0.05).Conclusion:In patients with acute cerebral infarction using simvastatin has significant clinical effect, can effectively reduce serum levels of IL-6 and CRP, anti-inflammatory effect

您可能关注的文档

文档评论(0)

ganpeid + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档